Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing. | Nat Commun | 2022 | 35241646 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers. | Cancer Cell Int | 2022 | 35241075 | PubTator, text mining | PubMed |
| Loss of MIG-6 results in endometrial progesterone resistance via ERBB2. | Nat Commun | 2022 | 35232969 | PubTator, text mining | PubMed |
| Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. | Nat Cancer | 2022 | 35228749 | PubTator, text mining | PubMed |
Oral exposure to high-dose ethanol for 28 days in rats reduces neural stem cells and immediate nascent neural progenitor cells as well as FOS-expressing newborn granule cells in adult hippocampal neurogenesis. | Toxicol Lett | 2022 | 35227807 | PubTator, text mining | PubMed |
| A mechanism of origin licensing control through autoinhibition of S. cerevisiae ORC·DNA·Cdc6. | Nat Commun | 2022 | 35217664 | PubTator, text mining | PubMed |
| A Novel Role of Arrhythmia-Related Gene KCNQ1 Revealed by Multi-Omic Analysis: Theragnostic Value and Potential Mechanisms in Lung Adenocarcinoma. | Int J Mol Sci | 2022 | 35216393 | PubTator, text mining | PubMed |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses. | Toxicol Appl Pharmacol | 2022 | 35189178 | PubTator, text mining | PubMed |
| Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A. | Haemophilia | 2022 | 35182444 | PubTator, text mining | PubMed |
| DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells. | Int J Biol Sci | 2022 | 35173548 | PubTator, text mining | PubMed |
| Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis. | Theranostics | 2022 | 35154475 | PubTator, text mining | PubMed |
| MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers. | Diagn Pathol | 2022 | 35125121 | PubTator, text mining | PubMed |
| Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort. | Nat Genet | 2022 | 35115689 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. | Nature | 2022 | 35110735 | PubTator, text mining | PubMed |
| Subtyping of sarcomas based on pathway enrichment scores in bulk and single cell transcriptomes. | J Transl Med | 2022 | 35093080 | PubTator, text mining | PubMed |
| Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer. | Sci Rep | 2022 | 35087187 | PubTator, text mining | PubMed |
| Novel evidence of obesity paradox in esophageal adenocarcinoma: perspective on genes that uncouple adiposity from dismal outcomes. | J Cancer | 2022 | 35069893 | PubTator, text mining | PubMed |
| CMG helicase can use ATPγS to unwind DNA: Implications for the rate-limiting step in the reaction mechanism. | Proc Natl Acad Sci U S A | 2022 | 35042821 | PubTator, text mining | PubMed |
| Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis. | Cancer Cell Int | 2022 | 35033076 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=24